The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species - Natural Product Reports (RSC Publishing)
Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds - Natural Product Reports (RSC Publishing)
The traditional Chinese medical compound Rocaglamide protects nonmalignant primary cells from DNA damage-induced toxicity by inhibition of p53 expression | Cell Death & Disease
Rocaglamide A - List of Frontiers' open access articles
Rocaglamide, inhibitor of NF-kappaB activation (CAS 84573-16-0) (ab142130)
Rocaglamide A - List of Frontiers' open access articles
Rocaglamide - an overview | ScienceDirect Topics
Total Synthesis of (±)-Rocaglamide via Oxidation-Initiated Nazarov Cyclization | The Journal of Organic Chemistry
Reanalysis of ribosome profiling datasets reveals a function of rocaglamide A in perturbing the dynamics of translation elongation via eIF4A | Nature Communications
Evidence for a Functionally Relevant Rocaglamide Binding Site on the eIF4A–RNA Complex | ACS Chemical Biology
Rocaglamide, a natural anti-cancer by Inès Hugonneau Beaufet
Rocaglamide Derivatives Are Potent Inhibitors of NF-κB Activation in T-cells - ScienceDirect
Rocaglamide | C29H31NO7 | CID 331783 - PubChem
Molecular mechanisms and anti‐cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines) - Li‐Weber - 2015 - International Journal of Cancer - Wiley Online Library
Rocaglamide | CAS# 84573-16-0 | 1863 | BioVision, Inc.
Evidence for a Functionally Relevant Rocaglamide Binding Site on the eIF4A–RNA Complex | ACS Chemical Biology